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Objective: To define reporting standards for IDEAL format studies.   
Background: The IDEAL Framework and Recommendations establish an integrated pathway 
for evaluation of new surgical techniques and complex therapeutic technologies. However 
guidance on implementation has been incomplete, and incorrect use is commonly seen.  We 
describe the consensus development of reporting guidelines for the IDEAL stages, and plans 
for their dissemination and evaluation. 
Methods: Using the EQUATOR Network recommendations, participants with knowledge of 
IDEAL were surveyed to determine which IDEAL stages needed reporting guidelines. Draft 
checklists for stages 1,2a, 2b and 4 were subsequently developed by 3 researchers (NB, AH, 
PMcC), and revised through a two-round Delphi consensus process.  A final consensus 
teleconference resolved outstanding disagreements and clarified wording for checklist 
items. 
Results: 61 participants completed the initial survey, a clear majority indicating that new 
reporting guidelines were needed for IDEAL Stage 1 (69.5%), Stage 2a (78%), Stage 2b 
(74.6%), and Stage 4 (66%). A proposed set of checklists was modified by survey participants 
in two online Delphi rounds (n=54 and n=47 respectively), resulting in a penultimate 
checklist for each stage. Fourteen expert working group members finalised the checklist 





Conclusions: Participants familiar with IDEAL called for reporting guidelines for studies in all 
IDEAL stages except stage 3. The checklists developed have the potential to improve 
standards of reporting and thereby advance the quality of research on surgery and complex 






Surgical innovation is recognized as having unique methodological and practical barriers 
that make rigorous evaluation and quality reporting inherently complex.1  The  IDEAL (Idea, 
Development, Exploration, Assessment, Long Term Study) Framework and 
Recommendations were introduced in 2009 to clarify and address  the key challenges 
presented in surgical innovation 2. The IDEAL integrated evaluation pathway guides the 
conduct and reporting of clinical studies of the outcomes of surgery and complex 
therapeutic interventions. The IDEAL Framework has evolved over time, and now includes a 
model for medical devices evaluation, IDEAL-D, and a modified framework for physical 
therapy and rehabilitation, IDEAL-Physio3,4,5,6.   
Although widely accepted in principle, the use of the IDEAL recommendations in practice to 
date has been limited and in many cases sub-optimal. Surveys of publications using IDEAL 
have shown that reporting of the stages was often inaccurate and the key features which 
define each stage were frequently omitted7,8,9.  The IDEAL Recommendations introduce 
several novel ideas into clinical study design, and following other published guidelines alone 
is therefore unlikely to enable authors to report them accurately.  The lack of clear and 
detailed instructions on reporting has been considered to be a barrier to wider adoption of 
IDEAL, and there have been calls for the development of reporting guidelines specific to 
IDEAL 10,11.   
Reporting Guidelines 
The EQUATOR Network (http://www.equator-network.org) defines a reporting guideline as 
a simple, structured tool for health researchers to use while writing manuscripts to guide 




explicit methodology and provide a minimum list of information needed to ensure a 
manuscript can be understood and assessed by a reader, replicated by a researcher, used to 
make a clinical decision, and included in a systematic review. There are now over 400 
checklists on the EQUATOR Network’s website, including 42 that are surgery related 
(http://www.equator-network.org/reporting-guidelines/). Among these existing reporting 
guidelines applicable to surgery SCARE 13, PROCESS 14, STROCSS 15 and CONSORT NPT 16 aim 
to improve the reporting of specific, well-recognised study types (case reports, case series, 
cohort studies and randomized controlled trials). Additional guidance exists for specific 
aspects of surgical evaluative study designs. For example TIDIER 17 has been developed as an 
extension of CONSORT to improve reporting of intervention details, and the COHESIVE 18 
guidelines are being developed for a generic core outcome set in studies of early phase 
surgery and medical devices. A CONSORT extension for RCTs using cohorts and routinely 
collected health data is also underway 19. Additionally the National Evaluation System for 
Health Technology Coordinating Center (NESTcc) Methods Framework has been developed 
to define the key components of study design, protocols and evidence gathering for the 
evaluation of medical devices 20 
All these guidelines draw upon principles of good research methodology, as does the IDEAL 
framework.  However the IDEAL reporting guidelines have a unique and specific focus on 
stepwise evaluation of surgical innovation through all stages of its development, from pre-
clinical to first in human evidence, feasibility and randomized trials to long-term follow-up 
and real-world data. Throughout these stages, IDEAL prescribes specific novel study formats, 
focussing on clarity about key elements of surgical innovation with which many researchers 




attempting to follow the IDEAL recommendations and suggests a pressing need for IDEAL 
reporting guidelines.  
The development of such IDEAL specific guidelines would serve to improve the usability and 
impact of IDEAL. As Altman and Moher state, “reporting problems affect journal articles in 
two main ways. First, the study methods are frequently not described in adequate detail. 
Second, the study findings are presented ambiguously, incompletely, or selectively. The 
cumulative effect of these problems is to render many reports of research unusable or even 
harmful; at the very least, such papers certainly represent a waste of resources”21. Chalmers 
and Glasziou have highlighted the detrimental effects of waste in the production and 
reporting of research evidence and call for increased use of reporting guidelines as part of 
the solution. 22 
This paper describes the development of a set of IDEAL reporting guidelines which aim to 
improve the quality, transparency, consistency, and utility of the surgical innovation 




We developed the IDEAL reporting guidelines through a five-phase process between 
October 2018 and May 2019. This comprised (1) identifying existing relevant reporting 
guidelines and those in development registered on the EQUATOR Network website 
(http://www.equator-network.org), (2) a survey to establish which stages of IDEAL, if any, 
participants  considered in need of new reporting guidelines, (3) the development of draft 




two rounds of a Delphi consensus survey to refine each of the checklists, and (5) a 
consensus meeting via teleconference with the working group to finalise the checklists.  
Participants: 
Using our MailChimp e-newsletter, we contacted 445 individuals who met at least one of 
four criteria: (1) member of the original IDEAL steering group; (2) a wider member of the 
IDEAL Collaboration signed up to receive newsletters; (3) author or co-author of any key 
core IDEAL publication; (4) attended one or more of the 2016, 2017, and 2018 IDEAL 
conferences. From this group, 119 expressed interest in participating, and those individuals 
were invited to complete an online survey about the need for reporting guidelines for any 
stage of IDEAL, as defined by the EQUATOR Network’s suggested criteria. 24  The 61 
respondents recommended that new reporting guidelines should be developed for Stage 1 
(69%), Stage 2a (78%), Stage 2b (75%), and Stage 4 (66%) (Supplementary Figure 1). IDEAL 
Stage 3 was considered adequately covered by existing guidelines (CONSORT, CONSORT NPT 
and other relevant extensions) by 68% of respondents. Characteristics of responding 
participants are shown in Table 1.  Fourteen volunteers from groups (1) and (3) formed a 
working group to agree the final checklists during the final consensus call. 
Development of Checklists:  
The initial drafts of checklists for the four stages were developed using a combination of 
approaches to identify what key items may be needed. These included ongoing monitoring 
of the literature using or commenting on the usability of IDEAL identified from Google 
Scholar and Web of Science Alerts of papers citing the 2009 and 2019 IDEAL Statement 
papers. Assessing gaps in existing reporting guidelines, and accumulated refinements of 




seminars and lectures on IDEAL. These checklists were evaluated in two rounds of a Delphi 
consensus survey using a nine-point Likert scale, (as recommended by GRADE), to rate 
agreement on the importance of each element and elicit free-text comments on the 
wording of each item25,26. In the Likert scale, a score of 1–3 signified limited importance of 
the item, 4–6 important but not critical, and 7–9 critical. If 70% or more of respondents 
scored an item 7–9 and fewer than 15% scored it 1–3, then that item was included in the 
reporting guideline.  Conversely, consensus that an item should not be included was defined 
as 70% or more scoring it 1–3 and 15% or less scoring it 7–9. Following round one, the 
authors reviewed the responses (n=54) and two reviewers (NB, AH) modified the checklist 
drafts based on the participants scoring and feedback, editing phrasing and wording of 
checklist items and merging redundant items, but ensuring meaning was not significantly 
changed. Round two of the Delphi survey presented the results of round one to participants, 
addressed clarifications and served to refine the checklist items where consensus was not 
yet reached. Participants were again asked to score the Round 2 checklist items on a 1-9 
Likert Scale.  
The responses from round two (n=47) were compiled for review by 2 researchers (NB, AH) 
and presented to the working group during the final teleconference consensus meeting. 
Consensus Teleconference: 
A consensus call held in May 2019 was attended by eleven of the fourteen members of the 
working group. Three participants who were unable to attend submitted written 
contributions via email. A draft of the methods, checklist drafts for each stage, and a 
provisional list of items where the Delphi process had not yielded a definitive result were 




were discussed and modifications were made once the group reached agreement. All 
checklist items for each stage were then reviewed and revised as needed to ensure clarity. 
The group also decided on a strategy to disseminate the checklists.  The revisions were then 
sent out to the participants for final comment and approval.   
Results 
The citation alerts and search of the EQUATOR Network list of reporting guidelines revealed 
no specific guidelines dealing with the IDEAL Recommendations as an entity either as the 
sole focus of study or as part of a larger ambit, and no guidelines which specifically 
described how to report IDEAL format studies.  Numerous guidelines contained generic 
recommendations also included by IDEAL, e.g. use of standard outcome definitions, 
publication of protocols and full informed consent, but none referenced IDEAL as a special 
case. 14-19 
Supplementary Figures 2 and 3 show the distribution of Scores for each checklist item in 
Rounds 1 and 2 respectively of the Delphi process. The 4 unresolved issues following Round 
2, discussed during the final consensus call were:  Inclusion of IDEAL and the stage number 
in titles; inclusion of “first-in-human” in the title of Stage 1 studies; mandatory publication 
of a prior protocol for all studies; and how to resolve tensions between commercial 
confidentiality and ethical demands for transparency in early stage studies involving devices. 
The solutions to each are incorporated in the final full checklists presented here. 
IDEAL Checklists 
IDEAL is based on ethical and methodological principles which apply to all stages and types 




paradigms and checklists.  Table 2 presents the full checklists for IDEAL Stages 1, 2a, 2b and 
4 and highlights key or unique IDEAL items with an example from the literature which 
illustrates appropriate use. The quoted paper does not necessarily demonstrate good 
reporting for other IDEAL recommendations. 
Discussion 
The IDEAL Recommendations include several innovations in study design for clinical 
research, such as reporting of iterative modifications and monitoring of learning curves.  
Because of this, the diligent use of other guidelines cannot help investigators to report 
IDEAL studies appropriately, and an IDEAL-specific guideline is required.  For example 
comparing  the SCARE guidelines for surgical case reports 13 and the IDEAL Stage 1 
recommendations,  IDEAL specifies requirements absent from SCARE (Applicability only to 
first-in-human studies, justify need and refer to pre-clinical development, detailed account 
of patient selection, requirement for fully informed consent for treatment, requirement for 
explanation of procedure detailed enough to allow reproduction).   
The IDEAL checklists are intended to provide a minimum list of concepts authors should 
include in a report of an IDEAL format study. They have been created for wide-spread 
adoption across all interventional specialties, including therapeutic devices, for which  IDEAL 
has published a modified framework, IDEAL-D5.  The checklists are equally usable for IDEAL 
and IDEAL-D studies, most items pertaining to both surgical and device innovation.  While 
not designed expressly for these purposes, the guidelines can also be used both 
prospectively to help plan a study and retrospectively to assist in appraisal. They can also be 




for core outcomes reporting, CONSORT extension for routinely collected health data for 
Stage 4). 18,19  
Dissemination and evaluation of IDEAL checklists 
Checklists are not effective unless used, so dissemination efforts are important.  The 
EQUATOR network 27 recommends 10 specific actions to aid dissemination: making the 
checklist freely accessible in editable format; publishing and presenting editorials, blogs, 
website pages, conference papers and webinars, co-operating with EQUATOR, seeking 
journal endorsements and running training courses.  We intend to follow this guidance 
utilising our website and Twitter accounts (www.ideal-collaboration.net and @IDEALCollab). 
Some specific elements of our strategy will be the use of social media to establish a 
feedback dialogue with users, presentation of the guidelines at conferences and scientific 
meetings, editorials and blogs, and translation into Chinese and Spanish to maximise 
international readership.  In line with EQUATOR guidance, we will pilot the checklist in 
ongoing IDEAL format studies, for which we will shortly be introducing an advisory service, 
and will publish an updated version with any modifications resulting from both feedback 
and piloting.  A pre-post guideline publication survey of reporting of IDEAL format studies to 
evaluate the effectiveness of these efforts will be developed at a future date.  Endorsement 
by authoritative bodies and efforts by editors to encourage or enforce compliance were 
features of the development and spread of the CONSORT guidelines, which appear to be the 
best complied with to date, so we will continue to seek support in these sectors. 
Limitations 
Like all consensus processes, our Delphi study was dependent on the representativeness of 




would be unlikely to be able to appreciate some of the issues or achieve consensus.  We 
attempted to include a wide range of stakeholders but were not universally successful.  The 
number of journal editors, for example, was small.  A different group might have come up 
with different recommendations, but no major differences in responses could be detected 
according to background in our sample. Although consensus was achieved by GRADE criteria 
on the need for a guideline in all stages except Stage 3, the minority which disagreed was 
substantial (around 25%) in each case.  Informal feedback indicates that this may have been 
because participants familiar with IDEAL had come to see reporting of IDEAL stage items as 
straightforward, and not needing guidance.  Some participants also mentioned the 
proliferation of reporting guidelines as a reason for caution. 
Conclusions 
The consensus-based checklists developed through this Delphi process have the potential to 
improve the standards of reporting of early stage innovation and surgical trials and thereby 
advance the quality of research on surgery and complex interventions. Surgical innovation 
and research that follows a transparent, sequential framework such as IDEAL and is 
reported with these guidelines can also aid reproducibility, reduce research waste and 
improve evidence-based practice for the benefit of patients. 
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